An official website of the United States government
Home
This neoplasm is not reportable.
Name
Angioimmunoblastic lymphadenopathy (AIL)
ICD-O-3 Morphology
9767/1: Angioimmunoblastic lymphadenopathy
Effective
2001 and later
Reportability
This neoplasm is not reportable
Primary Site(s)
No primary site specified
This hematopoietic disease is not reportable for the U.S. except for primary sites C700-C729, C751-C753.
Canada, refer to your specific province for reportability requirements.
Canada, refer to your specific province for reportability requirements.
Abstractor Notes
If the diagnosis is angioimmunoblastic lymphadenopathy assign 9767/1. If the dx is angioimmunoblastic lymphadenopathy with dysproteinemia, assign to 9705/3.
Alternate Names
Immunoblastic lymphadenopathy (IBL) [OBS]
Corresponding ICD-10 Codes (Cause of Death codes only)
D47.7 Other specified neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue
Corresponding ICD-10-CM Codes (U.S. only)
D47.Z9 Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue (effective October 01, 2015)
Sources
International Classification of Diseases for Oncology, Third Edition, Second Revision. Geneva: World Health Organization, 2020.
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577
